- Short report
Homer1a signaling in the amygdala counteracts pain-related synaptic plasticity, mGluR1 function and pain behaviors
Molecular Painvolume 7, Article number: 38 (2011)
Group I metabotropic glutamate receptor (mGluR1/5) signaling is an important mechanism of pain-related plasticity in the amygdala that plays a key role in the emotional-affective dimension of pain. Homer1a, the short form of the Homer1 family of scaffolding proteins, disrupts the mGluR-signaling complex and negatively regulates nociceptive plasticity at spinal synapses. Using transgenic mice overexpressing Homer1a in the forebrain (H1a-mice), we analyzed synaptic plasticity, pain behavior and mGluR1 function in the basolateral amygdala (BLA) in a model of arthritis pain.
In contrast to wild-type mice, H1a-mice mice did not develop increased pain behaviors (spinal reflexes and audible and ultrasonic vocalizations) after induction of arthritis in the knee joint. Whole-cell patch-clamp recordings in brain slices showed that excitatory synaptic transmission from the BLA to the central nucleus (CeA) did not change in arthritic H1a-mice but increased in arthritic wild-type mice. A selective mGluR1 antagonist (CPCCOEt) had no effect on enhanced synaptic transmission in slices from H1a-BLA mice with arthritis but inhibited transmission in wild-type mice with arthritis as in our previous studies in rats.
The results show that Homer1a expressed in forebrain neurons, prevents the development of pain hypersensitivity in arthritis and disrupts pain-related plasticity at synapses in amygdaloid nuclei. Furthermore, Homer1a eliminates the effect of an mGluR1 antagonist, which is consistent with the well-documented disruption of mGluR1 signaling by Homer1a. These findings emphasize the important role of mGluR1 in pain-related amygdala plasticity and provide evidence for the involvement of Homer1 proteins in the forebrain in the modulation of pain hypersensitivity.
Neuroplasticity in the amygdala plays an important role in emotional-affective aspects of pain [1, 2]. A growing body of literature is addressing pain-related functions of different amygdala nuclei and signaling mechanisms in these areas [3–13, 13–16]. Neurotransmission from the lateral amygdala (LA) to the basolateral amygdala (BLA) and further to the central nucleus of the amygdala (CeA) regulates input and output functions of the amygdala. The designation of the latero-capsular division of the central nucleus of the amygdala (CeLC) as the "nociceptive amygdala" emphasizes its role in pain processing and modulation [1, 2]. CeLC neurons receive excitatory glutamatergic input directly from neurons in the BLA and inhibitory input via glutamatergic activation of GABAergic neurons in the intercalated cell mass of the amygdala .
Group I metabotropic glutamate receptors (mGluR1/5) play an important role in pain-related signaling in the amygdala [3, 13–16]. Pain-related neuroplastic changes of excitatory transmission from the BLA to the CeLC are mainly mediated by mGluR1 . Blockade of mGluR1 inhibits arthritis pain-induced audible and ultrasonic vocalizations in rats  and decreases excitatory postsynaptic currents (EPSCs) in CeLC neurons in brain slices of arthritis rats [3, 6].
Activation of mGluR1/5 leads to the release of intracellular calcium via phospholipase C, which has major cellular consequences such as neuronal excitability changes, enhancement of neurotransmitter release, and potentiation of the activity of NMDA or AMPA receptors [17–20]. Signaling of mGluR1/5 is potently modulated by the family of Homer proteins [21, 22]. Homer1 proteins bind to mGluR1/5, and the long splice variants Homer1b and Homer1c, which are constitutively expressed, function as molecular bridges by linking mGluR1/5 to the IP3 receptor on the endoplasmatic reticulum [21–23], thereby regulating mGluR-IP3R signaling towards the release of calcium from intracellular stores . The short splice variant Homer1a has been identified as an immediate early gene (IEG) following intense neuronal activity [22, 25, 26]. Expression of Homer1a leads to the disruption of the mGluR-IP3R complex [21, 23] and to reduced and delayed mGluR-mediated intracellular calcium release . Homer1a has been associated with pain-related plasticity at spinal synapses [27–30] and serves as a endogenous modulator for negative feedback regulation of mGluR-signaling in inflammatory pain conditions . However, pain modulation by Homer1 signaling in the brain is entirely unknown. We explored the contribution of the Homer1a-mGluR signaling complex to pain hypersensitivity and pain-related synaptic plasticity in the amygdala, using Homer1a transgenic mice.
This study addressed the interaction of Homer1a and mGluR1 in the amygdala in our kaolin/carrageenan-induced arthritis pain model. We generated mice overexpressing Homer1a in the forebrain and characterized different founder lines .
Generation and maintenance of transgenic mice
The Homer1a-transgenic mouse line was generated, backcrossed to C57BL/6 wild-type strain for more than 10 generations and characterized as described previously . Mice were housed individually in a temperature and 12 h day/night cycle controlled room. All experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Texas Medical Branch (UTMB) and conform to the guidelines of the International Association for the Study of Pain (IASP) and of the National Institutes of Health (NIH).
Arthritis pain model
A mono-arthritis was induced in one knee joint as described in detail previously . Briefly, a kaolin suspension (4%, 40 μl) was slowly injected into the joint cavity through the patellar ligament. After repetitive flexions and extensions of the knee for 15 min, a carrageenan solution (2%, 40 μl) was injected into the knee joint cavity, and the leg was flexed and extended for another 5 min. The control group of mice was untreated. We showed previously that intraarticular saline injection does not mimic arthritis-induced changes .
Hindlimb withdrawal reflexes were evoked by mechanical stimulation of the knee joint with increasing intensities, using a forceps equipped with a force transducer system as in our previous studies [5, 13, 32]. Withdrawal threshold was defined as the minimum stimulus intensity that evoked a withdrawal reflex.
Audible (16-20 kHz) and ultrasonic (25 ± 4 kHz) vocalizations were recorded and analyzed as described previously [32, 33] using the UltraVox 4-channel system; Noldus Information Technology, Leesburg, VA. Vocalizations were recorded for 1 min before and during application of brief (15 s) innocuous (500 g/30 mm2) and noxious (2000 g/30 mm2) mechanical stimuli to the knee, using a calibrated forceps [32, 33].
Electrophysiology: patch-clamp recording
Coronal brain slices (300 μm) containing the CeCL were prepared from normal and arthritic mice (6 h postinduction) as described before in rats [3, 6, 8–11]. Briefly, mice were decapitated and the brains were quickly dissected out and blocked in cold, oxygenated artificial cerebrospinal fluid (ACSF). Whole-cell patch-clamp recordings were obtained from CeLC neurons using the "blind" patch technique as previously described [3, 6, 8–11]. One neuron was recorded in each slice and 1 or 2 slices were used per animal. 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) was purchased from Tocris Bioscience (Ellisville, MO) and applied by gravity-driven superfusion in the ACSF. The appropriate concentration was determined in our previous study .
All data are presented as mean ± SE. For multiple comparisons, Analysis of Variance (ANOVA) was used. Paired Student's t-test was used to compare two sets of data that have Gaussian distribution and similar variances.
Homer1a expression in H1a-mice
Immunohistochemistry was used to detect the expression of the myc-tagged Homer1a protein. Here we used a transgenic line overexpressing Homer1a uniformly strong in the striatum, in layers V and VI of the somatosensory cortex, and in the amygdala (Figure 1). In the amygdala, Homer1a was mainly expressed in the BLA and to a lesser extend in the lateral amygdala (LA; Figure 1). We used this myc-tagged Homer1a-overexpressing mouse-line ("H1a-mice") to address the significance of the mGluR1 signaling in amygdala neurons in arthritis pain. Non-Homer1a expressing littermates were used as control mice ("wild type").
Pain behavior in H1a-mice
The knee joint arthritis led to the development of increased pain responses in wild-type mice, which is reflected in the decrease of hindlimb withdrawal thresholds (n = 3; Figure 2A) and an increase in the duration of audible and ultrasonic vocalizations (n = 6; Figures 2B and 2C) measured 6 h postinduction. In contrast, H1a-mice did not develop mechanical hypersensitivity (n = 3; Figure 2A) and showed no change in vocalizations (n = 6; Figures 2B and 2C), suggesting that the expression of Homer1a protects against arthritis pain.
Synaptic transmission in the amygdala in H1a-mice
We went on to investigate the effect of Homer1a overexpression on pain-related changes of excitatory synaptic transmission and mGluR1 function in the CeLC. Whole-cell patch-clamp technique was used to record monosynaptic EPSCs evoked in CeLC neurons by electrical stimulation in the BLA in brain slices from wild type and from H1a-mice, with or without arthritis (6 h postinduction, Figure 3). In agreement with previous studies in rats [3, 6, 8–11], input-output functions of excitatory transmission increased in CeLC neurons in wild-type mice with arthritis (n = 5 neurons) compared to mice without arthritis (n = 4) significantly (P < 0.0001, F1,70 = 39.53; Figure 3A). Blockade of mGluR1 with a selective antagonist (CPCCOEt, 10 μM, n = 5 neurons) inhibited excitatory synaptic transmission significantly in wild-type mice with arthritis (P < 0.01, paired t-test, compared to predrug; Figures 3C and 3D). Our previous studies showed that this effect was presynaptic [3, 6]. In H1a-mice, baseline excitatory synaptic transmission (no arthritis, n = 4 neurons; Figure 3B) was not significantly different from that in wild-type mice (P > 0.05, F1,60 = 3.63; Figure 3A). Different than in wild-type mice, however, excitatory synaptic transmission in H1a-mice did not change in arthritis (n = 5 neurons, P > 0.05, F1,70 = 3.86; Figure 3B). Importantly, CPCCOEt (10 μM) had no effect on excitatory transmission in slices from H1a-mice with arthritis (n = 5 neurons; Figures 3C and 3D).
Our findings confirm previous studies performed in rats where mGluR1 has been shown to play an important role in pain-related synaptic plasticity in the CeLC [3, 6]. The novel result of the present study is that interactions of mGluR1 with the scaffolding proteins of the Homer1 family in the forebrain play an important role in inflammatory pain hypersensitivity as well as in synaptic plasticity in the amygdala. Homer1a serves here as an endogenous "antagonist" of group I mGluR signaling as proposed previously in the spinal cord [22, 27, 34] and prevents pain-related behavioral and synaptic changes. As in our previous study in rat brain slices  the mGluR1 antagonist CPCCOEt had no effect on synaptic transmission under normal conditions but strongly inhibited synaptic transmission in arthritis rats. However, this effect was lost in mice overexpressing Homer1a, which can be explained by Homer1a disrupting mGluR1 signaling hence occluding the inhibitory effect of the mGluR1 antagonist seen in wild-type mice. The disruptive effect of Homer1a overexpression in the BLA rather than CeA is consistent with a presynaptic site of action previously shown for mGluR1 at the BLA-CeA synapse [3, 6].
Our findings emphasize the importance of mGluR1-Homer1 interactions in amygdala neurons in pain and provide evidence for a protective role of the activity-induced regulator, Homer1a, in the forebrain in inflammatory pain. It is conceivable that expression of Homer1a in forebrain areas other than the amygdala may also disrupt pain-related synaptic plasticity and prevent the development of pain hypersensitivity. Candidate brain areas include the anterior cingulate cortex and insular cortex. Disrupting pain-related plasticity in the anterior cingulate cortex has recently been shown to alleviate neuropathic pain .
artificial cerebrospinal fluid
basolateral nucleus of the amygdala
central nucleus of the amygdala
latero-capsular division of the CeA
7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester
excitatory postsynaptic current
lateral nucleus of the amygdala
metabotropic glutamate receptor.
Neugebauer V, Galhardo V, Maione S, Mackey SC: Forebrain pain mechanisms. Brain Res Rev 2009, 60: 226–242. 10.1016/j.brainresrev.2008.12.014
Neugebauer V, Li W, Bird GC, Han JS, (Eds): The amygdala and persistent pain. Neuroscientist 2004, 10: 221–234. 10.1177/1073858403261077
Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW, (Eds): Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci 2003, 23: 52–63.
Palazzo E, Fu Y, Ji G, Maione S, Neugebauer V: Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors. Neuropharmacology 2008, 55: 537–545. 10.1016/j.neuropharm.2008.05.007
Han JS, Adwanikar H, Li Z, Ji G, Neugebauer V: Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain 2010, 6: 10–23. 10.1186/1744-8069-6-10
Ren W, Neugebauer V: Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1. Mol Pain 2010, 6: 93. 10.1186/1744-8069-6-93
Carrasquillo Y, Gereau RW: Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J Neurosci 2007, 27: 1543–1551. 10.1523/JNEUROSCI.3536-06.2007
Han JS, Li W, Neugebauer V: Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci 2005, 25: 10717–10728. 10.1523/JNEUROSCI.4112-05.2005
Bird GC, Lash LL, Han JS, Zou X, Willis WD, Neugebauer V: Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J Physiol 2005, 564: 907–921. 10.1113/jphysiol.2005.084780
Fu Y, Neugebauer V: Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 2008, 28: 3861–3876. 10.1523/JNEUROSCI.0227-08.2008
Fu Y, Han J, Ishola T, Scerbo M, Adwanikar H, Ramsey C, Neugebauer V: PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain 2008, 4: 26–46. 10.1186/1744-8069-4-26
Ji G, Neugebauer V: Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons. J Neurophysiol 2010, 104: 218–229. 10.1152/jn.00223.2010
Li Z, Ji G, Neugebauer V: Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J Neurosci 2011, 31: 1114–1127. 10.1523/JNEUROSCI.5387-10.2011
Li W, Neugebauer V: Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J Neurophysiol 2004, 91: 13–24.
Han JS, Neugebauer V, (Eds): mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain 2005, 113: 211–222. 10.1016/j.pain.2004.10.022
Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, Muglia LJ, Gereau RW: Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci 2010, 30: 8203–8213. 10.1523/JNEUROSCI.1216-10.2010
Bordi F, Ugolini A: Group I metabotropic glutamate receptors: implications for brain diseases. Prog Neurobiol 1999, 59: 55–79. 10.1016/S0301-0082(98)00095-1
Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP: Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology 2010, 60: 1017–1041.
Niswender CM, Conn PJ: Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50: 295–322. 10.1146/annurev.pharmtox.011008.145533
Anwyl R: Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 1999, 29: 83–120.
Xiao B, Tu JC, Petralia RS, Yuan JP, Doan A, Breder CD, Ruggiero A, Lanahan AA, Wenthold RJ, Worley PF: Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 1998, 21: 707–716. 10.1016/S0896-6273(00)80588-7
Xiao B, Tu JC, Worley PF: Homer: a link between neural activity and glutamate receptor function. Curr Opin Neurobiol 2000, 10: 370–374. 10.1016/S0959-4388(00)00087-8
Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, Worley PF: Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 1998, 21: 717–726. 10.1016/S0896-6273(00)80589-9
Fagni L, Chavis P, Ango F, Bockaert J: Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci 2000, 23: 80–88. 10.1016/S0166-2236(99)01492-7
Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, Worley PF: Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 1997, 386: 284–288. 10.1038/386284a0
Kato A, Ozawa F, Saitoh Y, Fukazawa Y, Sugiyama H, Inokuchi K: Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J Biol Chem 1998, 273: 23969–23975. 10.1074/jbc.273.37.23969
Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, Ehrengruber MU, During MJ, Kuner R: Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat Med 2006, 12: 677–681. 10.1038/nm1406
Ma ZL, Zhu W, Zhang w, Gu XP: Effect of the synaptic scaffolding protein Homer1a on chronic compression of dorsal root ganglion. Ann Clin Lab Sci 2009, 39: 71–75.
Miletic G, Driver AM, Miyabe-Nishiwaki T, Miletic V: Early changes in Homer1 proteins in the spinal dorsal horn are associated with loose ligation of the rat sciatic nerve. Anesth Analg 2009, 109: 2000–2007. 10.1213/ANE.0b013e3181beea9b
Miyabe T, Miletic G, Miletic V: Loose ligation of the sciatic nerve in rats elicits transient up-regulation of Homer1a gene expression in the spinal dorsal horn. Neurosci Lett 2006, 398: 296–299. 10.1016/j.neulet.2006.01.011
Tappe A, Kuner R: Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. Proc Natl Acad Sci USA 2006, 103: 774–779. 10.1073/pnas.0505900103
Neugebauer V, Han JS, Adwanikar H, Fu Y, Ji G: Techniques for assessing knee joint pain in arthritis. Mol Pain 2007, 3: 8–20. 10.1186/1744-8069-3-8
Han JS, Bird GC, Li W, Neugebauer V, (Eds): Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior. J Neurosci Meth 2005, 141: 261–269. 10.1016/j.jneumeth.2004.07.005
Thomas U: Modulation of synaptic signalling complexes by Homer proteins. J Neurochem 2002, 81: 407–413. 10.1046/j.1471-4159.2002.00869.x
Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, Park SW, Shim J, Lee K, Collingridge GL, Kaang BK, Zhuo M: Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010, 330: 1400–1404. 10.1126/science.1191792
This work was supported by National Institute of Neurological Disorders and Stroke Grants NS-38261 and NS-11255 and funding from the Deutsche Forschungsgemeinschaft to R.K. (KO1438/3-1). A.T. is an Olympia Morata fellow at the Medical Faculty of the Heidelberg University.
The authors declare that they have no competing interests.
AT, generated the transgenic mice, performed histological analysis of Homer1a expression in the brain, and wrote the first draft of the manuscript. YF performed patch-clamp recordings and behavioral tests, analyzed data, and provided figures. RK supervised the transgenic experiments data analysis and RK and VN conceptualized the hypothesis. VN designed and supervised the electrophysiological and behavioral experiments and finalized the manuscript. All authors read and approved the manuscript.